Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1 Expression.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42793675

Aykut Özmen; Gökmen Umut Erdem; Nilüfer Bulut; Shamkal Safarov; Özde Melisa Celayir

Sep 27, 2026